Livea Review
Semaglutide & tirzepatide GLP-1 weight-loss clinic · Independently scored 7.2/10
Best for: semaglutide at $99/month, 48% under the register median
Livea falls below our bar on medical oversight. Read the breakdown below before you give it money.
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Charged on top
Coaching
In the price
No insurance needed · Vetted by our editors
Compounded semaglutide is priced from $99/mo, compounded tirzepatide from $199/mo when available. Bundled into the program: regular provider check-ins, health coaching, registered dietitian nutrition and InBody scans. Livea, a medical weight loss clinic with physician supervision, was founded in 2011, is LegitScript certified, and runs 8 clinics across MN and WI with telehealth in Florida, Iowa, MN and WI. Livea Medical, PLLC, a physician-owned practice, provides medical services. It claims 50,000+ clients and five straight Minnesota's Best Weight Loss Program wins.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Vetted alternatives to Livea
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Livea at a glance
- Type
- GLP-1 telehealth provider
- Starting price
- $99/mo (Verbatim from /glp-1/ FAQ: 'compounded semaglutide starting at $99/month.' Once-weekly injectable. Medical page discl...)
- What's included
- Medication · Consult · Shipping · Coaching
- Availability
- 4 states
- FDA status
- No FDA warning letter on record
How Livea scores
Six columns, each one computed from something Livea has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.
Value25%
9.7/10$99/month is 48% below the register median of $189 for compounded semaglutide.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
3.0/10On the seller's own pages, no price appears until the medical intake is finished.
Trust & Safety15%
5.0/10does not name a dispensing pharmacy; withholds price until after the intake; publishes its state list. Our verification confidence is medium.
Accessibility10%
2.6/10Publishes coverage in 4 of 50 states.
Support10%
8.5/10The price covers medication, consult, shipping, coaching.
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
What we checked on Livea
Last checked July 2026- Re-read the price on file across 2 dose or plan tiers
- Checked state coverage: 4 states
- Established what the monthly figure covers, and what it leaves out
- Searched our FDA enforcement register for this operator
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: medium.
What signing up with Livea involves
Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.
- 1Livea does not show a price until you have worked through its medical questionnaire. Budget for the fact that you cannot compare it against anything until you have handed over health information.
- 2The intake is a written questionnaire. No live video visit or baseline bloodwork is recorded as required.
- 3Livea does not say which pharmacy dispenses the medication. That is common here and it means you cannot check the pharmacy's record before you buy.
- 4The monthly price is recorded as covering medication, consult, shipping, coaching.
- Cheapest standing monthly prices on record: semaglutide $99, tirzepatide $199. Membership fees, first-month rates and insured copays are excluded from those figures.
- Coverage is published for 4 of 50 states.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Livea support, as documented
- Phone
- (855) 465-4832
GLP-1 medications Livea offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Verbatim from /glp-1/ FAQ: 'compounded semaglutide starting at $99/month.' Once-weekly injectable. Medical page discloses separate $69/mo program fee covering consultation and supervision — whether $99/mo is inclusive of or additive to the program fee is clarified at free consultation.
Verbatim from /glp-1/ FAQ: 'Compounded tirzepatide starts at $199/month when available.' Availability subject to FDA compounding status — as of mid-2026 Livea states the FDA shortage end affects compounded tirz; Livea monitors and offers eligibility-based options including branded alternatives.
Check the price yourself before you pay
Every figure here was read off Livea's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide at $99 a month, 48% below the $189 median for the same drug and form across this register
- The monthly figure covers medication, consult, shipping, coaching
- No FDA warning letter matched this operator when we searched our enforcement register
Against it
- No price appears until the medical intake is complete, so the cost cannot be compared before health information is submitted
- Billed separately from the monthly figure: labs
- Coverage is published for 4 states only, so this may not reach you
- No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Livea charges
The standing price at Livea is $99/month. That sits at the affordable end of what we track.
- Compounded semaglutide — $99/month
- Compounded tirzepatide — $199/month
Across the GLP-1 providers in our register the median standing price is about $169/month, so Livea is genuinely under the middle rather than merely advertising that it is.
TRYM Health dispenses semaglutide and tirzepatide from $96/month, which makes it the honest comparison to run before committing here.
What Livea dispenses
Livea prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it.
What we could verify
On the record: it operates in 4 states and coaching is included rather than sold on top. We searched the federal warning-letter record for this operator and came back with nothing. Because the medication is compounded and no dispensing pharmacy is named publicly, the single most useful question to ask at intake is which licensed pharmacy fills the prescription. A seller that will not answer that has told you something. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Nothing here is the approved finished product.
- You need to bill insurance. Like most of this market, this is cash-pay.
It fits if
- the lowest standing monthly cost is what you are solving for
- you want coaching bundled rather than metered
Our read
Livea competes on price and does it without an obvious sacrifice elsewhere: $99/month, no warning letter on file, and access that is not unusually restricted.
The Bottom Line
Livea falls below our bar on medical oversight. Read the breakdown below before you give it money.
Before you pay Livea
Starting at $99/month. Check today's price, then book the free consultation.
Where Livea is the wrong choice
No seller in this register suits every reader, and saying otherwise would be the easiest way to sell one. On these four counts another entry does better.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Livea review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Livea's current pricing
Plans start at $99/month. The free consultation is where you learn whether you qualify, and what it costs today.